Hosted on MSN2mon
Amneal gets FDA approval for generic Byetta, resubmits DHE NDA
Amneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the GLP-1 agonist diabetes drug Byetta and resubmitted its New Drug Application for a prefilled syringe ...
U.S. News & World Report9d
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easing its symtoms. The trial, published Feb. 4 in The Lancet ...